Bortezomib, bendamustine,and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II vertical study

Nathan Fowler, Brad S. Kahl, Peter Lee, Jeffrey V. Matous, Amanda F. Cashen, Samuel A. Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael E. Williams, Sonali Smith, Alfred Saleh, Peter Rosen, Hongliang Shi, Sudha Parasuraman, Bruce D. Cheson

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint Dive into the research topics of 'Bortezomib, bendamustine,and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II vertical study'. Together they form a unique fingerprint.

Medicine & Life Sciences